Krystal Biotech (NasdaqGS:KRYS) Earnings Call Presentation

KB407 for Cystic Fibrosis CORAL-1 Clinical Data Update January 2026 © Copyright 2026 Krystal Biotech, Inc. All rights reserved. Forward Looking Statements and Disclosures This presentation and our discussion contain forward-looking statements that involve substantial risks and uncertainties. Any statements about future expectations, plans, and prospects for Krystal Biotech, Inc. (the "Company"), including but not limited to statements about the Company's investigational product candidate, KB407, and the COR ...